Cyanocobalamin
Sponsors
Georgetown University, National Institute of Neurological Disorders and Stroke (NINDS), Ali Altunkaya, Emisphere Technologies, Inc., Universität des Saarlandes
Conditions
AdiposityBrain and Central Nervous System TumorsCerebral EdemaCerebral InfarctionCobalamin DeficiencyDrug EffectEnd Stage Renal DiseaseGlucose Intolerance
Early Phase 1
Phase 2
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
TerminatedNCT00243022
Start: 2004-09-30End: 2011-03-31Updated: 2019-04-30
Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine
NCT02773147
Start: 2016-04-30End: 2018-11-30Target: 60Updated: 2018-01-02
Early Infant Micronutrition and Development
RecruitingNCT05005897
Start: 2021-12-08End: 2029-10-15Target: 600Updated: 2023-04-18
Phase 3
Phase 4
Unknown Phase
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
CompletedNCT00004495
Start: 1999-06-30End: 2000-09-30Target: 84Updated: 2015-03-25
Oral Cyanocobalamin (Eligen B12) Bioavailability Study
CompletedNCT01311739
Start: 2008-05-31End: 2008-06-30Updated: 2011-03-09
Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status
CompletedNCT02679833
Start: 2014-11-30End: 2015-12-31Updated: 2018-05-11
Effectiveness of Vitamin b12 Versus Kenalog on Traumatic Ulcer Associated With Orthodontic Treatment
CompletedNCT07004465
Start: 2025-08-19End: 2026-02-28Updated: 2026-03-03